Affluent Medical SA (EPA:AFME)

France flag France · Delayed Price · Currency is EUR
1.435
-0.035 (-2.38%)
Sep 4, 2025, 12:58 PM CET
-2.38%
Market Cap57.84M
Revenue (ttm)5.35M
Net Income (ttm)-14.74M
Shares Out39.35M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,503
Average Volume15,763
Open1.450
Previous Close1.470
Day's Range1.390 - 1.450
52-Week Range1.160 - 1.990
Beta0.62
RSI47.63
Earnings DateSep 26, 2025

About Affluent Medical

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. Affluent Medical SA was founded in 2011 and is headquartered in Aix-en-Provence, France... [Read more]

Sector Healthcare
Founded 2011
Employees 63
Stock Exchange Euronext Paris
Ticker Symbol AFME
Full Company Profile

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.

Financial Statements

News

There is no news available yet.